Newfield Expl (NFX) recently had their rating increased from Hold to Buy. Stifel Nicolaus is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $80 per share by the brokerage firm. Shares of NFX fell by 1.62% or $-1.14/share to $69.30. In the past year, the shares have traded as low as $46.11 and as high as $77.93. On average, 2054980 shares of NFX exchange hands on a given day and today's volume is recorded at 732476.
Oppenheimer, the brokerage firm, has recently decreased the rating on Aeroflex (ARX). They lowered the rating from Outperform to Perform. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of ARX fell by 17.07% or $-3.19/share to $15.50. In the past year, the shares have traded as low as $12.60 and as high as $20.36. On average, 161522 shares of ARX exchange hands on a given day and today's volume is recorded at 1488318.
Immucor (BLUD) is currently being analyzed by the brokerage firm Robert W. Baird. They have just changed their rating from Outperform to Neutral. This indicates that the company may not be doing as well as investors were expecting. Look for potential selling pressure or a downside move in the share price. The target price is currently set at $27 per share by the brokerage firm. Shares of BLUD fell by 0.15% or $-0.0399/share to $26.94. In the past year, the shares have traded as low as $15.01 and as high as $27.19. On average, 936959 shares of BLUD exchange hands on a given day and today's volume is recorded at 2854534.
